Demographics, admission vital signs, and outcome data for all patients by VTE group
| . | No VTE (n = 121) . | VTE (n = 24) . | P value . |
|---|---|---|---|
| Demographics | |||
| Age (y) | 35 (28, 50) | 40 (25, 54) | .728 |
| Male, n (%) | 94 (77.7) | 15 (62.5) | .116 |
| Race, White, n (%) | 91 (75.2) | 18 (75.0) | .558 |
| Ethnicity, Hispanic/Latino, n (%) | 40 (33.1) | 9 (37.5) | .674 |
| Body mass index | 28 (24, 31) | 29 (26, 32) | .219 |
| Admission vital signs and laboratory tests | |||
| Heart rate (bpm) | 105 (85, 124) | 108 (94, 133) | .308 |
| Systolic blood pressure (mm Hg) | 123 (115, 150) | 110 (69, 136) | .243 |
| Base excess/deficit (mmol/L) | −2 (−4, −1) | −4.5 (−6.5, −2.0) | .188 |
| Injury | |||
| Blunt, n (%) | 110 (90.9) | 21 (87.5) | .732 |
| Glasgow Coma Scale | 14 (3, 15) | 3 (3, 15) | .058 |
| Injury Severity Score | 27 (17, 34) | 29 (20, 41) | .218 |
| AIS head >2, n (%) | 52 (43.0) | 11 (45.8) | .796 |
| Transfusion volumes (units) | |||
| 24-hour whole blood cells | 0 (0, 0) | 0 (0, 1) | .094 |
| 24-hour RBCs | 0 (0, 3) | 5 (1, 10) | .001∗ |
| 24-hour plasma | 1 (0, 3) | 2 (1, 13) | .005∗ |
| 24-hour platelets | 0 (0, 0) | 0 (0, 3) | .037∗ |
| 24-hour cryoprecipitate | 0 (0, 0) | 0 (0, 0) | .008∗ |
| Outcomes | |||
| Ventilator-free days | 28 (26, 30) | 27 (14, 30) | .186 |
| ICU-free days | 24 (21, 27) | 20 (8, 27) | .036∗ |
| Hospital-free days | 17 (9, 21) | 6 (0, 16) | .000∗ |
| In-hospital mortality, n (%) | 4 (3.3) | 2 (8.3) | .259 |
| . | No VTE (n = 121) . | VTE (n = 24) . | P value . |
|---|---|---|---|
| Demographics | |||
| Age (y) | 35 (28, 50) | 40 (25, 54) | .728 |
| Male, n (%) | 94 (77.7) | 15 (62.5) | .116 |
| Race, White, n (%) | 91 (75.2) | 18 (75.0) | .558 |
| Ethnicity, Hispanic/Latino, n (%) | 40 (33.1) | 9 (37.5) | .674 |
| Body mass index | 28 (24, 31) | 29 (26, 32) | .219 |
| Admission vital signs and laboratory tests | |||
| Heart rate (bpm) | 105 (85, 124) | 108 (94, 133) | .308 |
| Systolic blood pressure (mm Hg) | 123 (115, 150) | 110 (69, 136) | .243 |
| Base excess/deficit (mmol/L) | −2 (−4, −1) | −4.5 (−6.5, −2.0) | .188 |
| Injury | |||
| Blunt, n (%) | 110 (90.9) | 21 (87.5) | .732 |
| Glasgow Coma Scale | 14 (3, 15) | 3 (3, 15) | .058 |
| Injury Severity Score | 27 (17, 34) | 29 (20, 41) | .218 |
| AIS head >2, n (%) | 52 (43.0) | 11 (45.8) | .796 |
| Transfusion volumes (units) | |||
| 24-hour whole blood cells | 0 (0, 0) | 0 (0, 1) | .094 |
| 24-hour RBCs | 0 (0, 3) | 5 (1, 10) | .001∗ |
| 24-hour plasma | 1 (0, 3) | 2 (1, 13) | .005∗ |
| 24-hour platelets | 0 (0, 0) | 0 (0, 3) | .037∗ |
| 24-hour cryoprecipitate | 0 (0, 0) | 0 (0, 0) | .008∗ |
| Outcomes | |||
| Ventilator-free days | 28 (26, 30) | 27 (14, 30) | .186 |
| ICU-free days | 24 (21, 27) | 20 (8, 27) | .036∗ |
| Hospital-free days | 17 (9, 21) | 6 (0, 16) | .000∗ |
| In-hospital mortality, n (%) | 4 (3.3) | 2 (8.3) | .259 |
Data are presented as median (Q1, Q3) for continuous variables.
AIS, abbreviated injury scale; ICU, intensive care unit; RBC, red blood cell; Q, quartile.
Denotes P < .05.